The Clorox Company (FRA:CXX)
Germany · Delayed Price · Currency is EUR | Market Cap | 9.31B -37.4% |
| Revenue (ttm) | 5.86B -3.7% |
| Net Income | 655.68M +8.9% |
| EPS | 5.35 +10.8% |
| Shares Out | n/a |
| PE Ratio | 14.20 |
| Forward PE | 14.66 |
| Dividend | 4.22 (5.54%) |
| Ex-Dividend Date | Apr 22, 2026 |
| Volume | n/a |
| Open | 76.90 |
| Previous Close | 76.20 |
| Day's Range | 76.76 - 77.44 |
| 52-Week Range | 73.10 - 116.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 31, 2026 |
About The Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service p... [Read more]
Financial Performance
In fiscal year 2025, The Clorox Company's revenue was $7.10 billion, an increase of 0.16% compared to the previous year's $7.09 billion. Earnings were $810.00 million, an increase of 189.29%.
Financial numbers in USD Financial StatementsNews
The Clorox Company Transcript: 23rd annual dbAccess Global Consumer Conference
Leadership transition is underway with no immediate operational changes. The business is stabilizing after a major ERP upgrade, focusing on innovation and market share gains amid a volatile consumer environment. GOJO integration is progressing well, with financial discipline and digital transformation supporting future growth.
Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges
Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute c...
Clorox CEO stepping down for health reasons, company to begin CEO search
Clorox (CLX) CEO Linda Rendle has asked the Board of Directors to initiate a CEO search process, as she has made the decision to step down for health reasons. Rendle…
Clorox CEO to Step Down for Health Reasons
Clorox Chief Executive Officer Linda Rendle is stepping down for health reasons after more than 20 years at the company.
Clorox Board of Directors to Initiate Comprehensive CEO Search Process
Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Of...
Glad® Features Sesame Street's Oscar the Grouch in new Limited-Edition Packaging
New collaboration brings a playful twist to everyday trash routines, turning a household chore into a moment of humor and personality. OAKLAND, Calif.
Clorox to Present at dbAccess Global Consumer Conference
OAKLAND, Calif., May 13, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participate...
Hidden Valley™ Ranch Expands into Protein-Forward Snacking with New Line of Seasoned Chicken Dippers
Iconic Ranch Flavor Meets Ready ‑ to ‑ Eat Chicken in a New Product that Answers Consumers' Growing Need for Protein and Convenience LAS VEGAS, May 11, 2026 /PRNewswire/ -- Hidden Valley Ranch, the br...
The Clorox Company Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of The Clorox Company (NYSE: CLX). The investigation focuses on Clorox's execu...
Clorox price target lowered to $83 from $94 at Goldman Sachs
Goldman Sachs analyst Bonnie Herzog lowered the firm’s price target on Clorox (CLX) to $83 from $94 and keeps a Sell rating on the shares. Clorox reported a slight EPS…
Clorox price target lowered to $97 from $110 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Clorox (CLX) to $97 from $110 and keeps an Equal Weight rating on the shares. Sales struggles are persisting, particularly in litter…
Clorox price target lowered to $95 from $99 at JPMorgan
JPMorgan lowered the firm’s price target on Clorox (CLX) to $95 from $99 and keeps an Underweight rating on the shares.
Clorox price target lowered to $110 from $115 at Evercore ISI
Evercore ISI analyst Javier Escalante lowered the firm’s price target on Clorox (CLX) to $110 from $115 and keeps an Underperform rating on the shares.
Clorox price target lowered to $91 from $100 at Deutsche Bank
Deutsche Bank analyst Steve Powers lowered the firm’s price target on Clorox (CLX) to $91 from $100 and keeps a Hold rating on the shares.
Clorox price target lowered to $97 from $110 at Citi
Citi lowered the firm’s price target on Clorox (CLX) to $97 from $110 and keeps a Neutral rating on the shares. The firm updated the company’s model post the earnings…
Clorox price target lowered to $96 from $110 at UBS
UBS lowered the firm’s price target on Clorox (CLX) to $96 from $110 and keeps a Neutral rating on the shares. Clorox beat Q3 EPS expectations on lower SG&A but…
Clorox price target lowered to $85 from $102 at Barclays
Barclays lowered the firm’s price target on Clorox (CLX) to $85 from $102 and keeps an Underweight rating on the shares. The firm updated the company’s model post the earnings…
The Clorox Company Earnings Call Transcript: Q3 2026
Q3 results were mixed, with gross margin pressured by higher supply chain costs and delayed savings. ERP implementation is complete, innovation is strong in key segments, and the GOJO acquisition is expected to be accretive despite near-term margin dilution. Elevated input costs and inflation remain key risks.
The Clorox Company Earnings release: Q3 2026
The Clorox Company released its Q3 2026 earnings on April 30, 2026, summarizing the period's financial results.
The Clorox Company Quarterly report: Q3 2026
The Clorox Company has published its Q3 2026 quarterly earnings report on April 30, 2026.
Clorox Cuts Earnings Outlook Despite Higher Profit
The cleaning-products maker lowered its outlook for earnings per share to $4.78 to $4.98 for the year, down from previous guidance of $5.60 to $5.95.
Clorox cuts annual profit forecast on weak demand for cleaning products
Bleach maker Clorox cut its annual profit forecast on Thursday, hurt by weaker demand for its cleaning products as the impact of the U.S.-Israeli war on Iran raises costs.
Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook
OAKLAND, Calif., April 30, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the third quarter of fiscal year 2026, which ended March 31, 2026.
Clorox price target lowered to $139 from $151 at Jefferies
Jefferies analyst Kaumil Gajrawala lowered the firm’s price target on Clorox (CLX) to $139 from $151 and keeps a Buy rating on the shares. Clorox faces a challenging second half…
Clorox Announces April 30 Webcast of Third-Quarter Fiscal Year 2026 Results
OAKLAND, Calif., April 9, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its third-quarter fiscal year 2026 results on April 30, 2026.